Back
Equity Residential Vs. Corbus Pharmaceuticals Holdings Industry Stock Comparison
Buy
62
EQR
Equity Residential
Last Price:
64.04
Seasonality Move:
2.39%
Buy
55
CRBP
Corbus Pharmaceuticals Holdings
Last Price:
37.54
Seasonality Move:
-15.12%
Buy
62
Equity Residential (EQR)
is a Buy
Is Equity Residential a Buy, Sell or Hold?
- The current Equity Residential [EQR] share price is $64.04. The Score for EQR is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.
- EQR is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
55
Corbus Pharmaceuticals Holdings (CRBP)
is a Buy
Is Corbus Pharmaceuticals Holdings a Buy, Sell or Hold?
- The current Corbus Pharmaceuticals Holdings [CRBP] share price is $37.25. The Score for CRBP is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.
- CRBP is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
EQR Stock Price Chart
What is Equity Residential's stock price today?
-
The Equity Residential share price today is $64.04
The current trend is moderately bullish and EQR is experiencing slight selling pressure.
CRBP Stock Price Chart
What is Corbus Pharmaceuticals Holdings's stock price today?
-
The Corbus Pharmaceuticals Holdings share price today is $37.25
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CRBP is experiencing slight selling pressure.
EQR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.73 | Buy |
| Relative Strength Index (14 RSI): | 56.42 | Buy |
| Chaikin Money Flow: | -1016519 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (61.02 - 64.22) | Buy |
| Bollinger Bands (100): | (59.55 - 62.93) | Buy |
CRBP Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.25 | Sell |
| Relative Strength Index (14 RSI): | 50.46 | Buy |
| Chaikin Money Flow: | -42000 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (35.86 - 40.12) | Sell |
| Bollinger Bands (100): | (10.43 - 38.95) | Buy |
EQR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 64.25 | Sell |
| 20-day SMA: | 62.8 | Buy |
| 50-day SMA: | 62.2 | Buy |
| 200-day SMA: | 60.98 | Buy |
| 8-day EMA: | 64.02 | Buy |
| 20-day EMA: | 63.15 | Buy |
| 50-day EMA: | 62.22 | Buy |
| 200-day EMA: | 61.53 | Buy |
CRBP Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 36.09 | Buy |
| 20-day SMA: | 38.05 | Sell |
| 50-day SMA: | 37.07 | Buy |
| 200-day SMA: | 15.38 | Buy |
| 8-day EMA: | 36.54 | Buy |
| 20-day EMA: | 37.23 | Buy |
| 50-day EMA: | 34.53 | Buy |
| 200-day EMA: | 20.28 | Buy |
Equity Residential Earnings Growth & EQR Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.02 per share, an increase next quarter of $0.04 per share, a decrease this year of $0.05 per share, and an increase next year of $0.18 per share.
Corbus Pharmaceuticals Holdings Earnings Growth & CRBP Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.69 per share, a decrease next quarter of $0.00 per share, an increase this year of $5.66 per share, and an increase next year of $0.09 per share.
Equity Residential Technical Analysis
| Apr 18 | Apr 19 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | ||||||||||
| 18 | 19 | 22 | 23 | 24 | 25 | 26 | 29 | 30 | 01 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Corbus Pharmaceuticals Holdings Technical Analysis
| Apr 18 | Apr 19 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | ||||||||||
| 18 | 19 | 22 | 23 | 24 | 25 | 26 | 29 | 30 | 01 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||